Dicot Pharma AB (NGM: DICOT)

Dicot Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	17.1	47.34	9.38	30.33	20.33	12.22
Cash & Short-Term Investments	17.1	47.34	9.38	30.33	20.33	12.22
Cash Growth	-68.07%	404.88%	-69.08%	49.20%	66.30%	34.73%
Other Receivables	3.55	2.3	1.14	1.01	0.9	0.6
Receivables	3.55	2.3	1.14	1.01	0.9	0.6
Inventory	7.23	3.4	1.49	-	-	0.44
Prepaid Expenses	-	0.5	0.34	0.4	0.34	0.74
Total Current Assets	27.88	53.54	12.35	31.74	21.57	14.01
Property, Plant & Equipment	0.01	0.01	0.02	0.03	0.04	-
Long-Term Accounts Receivable	-	-	-	-	-	0.06
Total Assets	27.89	53.56	12.37	31.77	21.61	14.07
Accounts Payable	-	4.54	3.42	2.58	1.49	0.62
Accrued Expenses	-	3.98	1.19	0.66	0.37	0.55
Other Current Liabilities	10.44	0.64	2.41	0.19	0.09	0.11
Total Current Liabilities	10.44	9.16	7.01	3.42	1.95	1.27
Total Liabilities	10.44	9.16	7.01	3.42	1.95	1.27
Common Stock	5.72	5.72	17.14	12.86	5.46	2.05
Additional Paid-In Capital	180.6	180.76	86.15	81.67	53.2	32.22
Retained Earnings	-168.87	-142.09	-97.93	-66.18	-39	-21.46
Shareholders' Equity	17.45	44.39	5.36	28.35	19.66	12.8
Total Liabilities & Equity	27.89	53.56	12.37	31.77	21.61	14.07
Net Cash (Debt)	17.1	47.34	9.38	30.33	20.33	12.22
Net Cash Growth	-68.07%	404.88%	-69.08%	49.20%	66.30%	34.73%
Net Cash Per Share	0.02	0.09	0.08	0.47	0.71	1.23
Filing Date Shares Outstanding	817.56	817.56	137.1	102.9	43.67	16.36
Total Common Shares Outstanding	817.56	817.56	137.1	102.9	43.67	16.36
Working Capital	17.45	44.38	5.34	28.32	19.62	12.74
Book Value Per Share	0.02	0.05	0.04	0.28	0.45	0.78
Tangible Book Value	17.45	44.39	5.36	28.35	19.66	12.8
Tangible Book Value Per Share	0.02	0.05	0.04	0.28	0.45	0.78
Machinery	-	0.04	0.04	0.04	0.04	-

Source: S&P Capital IQ. Standard template. Financial Sources.